
    
      The purpose of this study is to establish the overall safety and tolerability of ARC1779 in
      healthy volunteers, and to characterize its pharmacokinetic and pharmacodynamic profile with
      respect to parameters of platelet function and von Willebrand Factor activity.
    
  